Microbiological Testing/Measurement TRIZ Cases

Low-depth sequencing at homozygous loci detects cross-contamination in biological samples without the cost and time of high-depth analysis.

Guide RNA directs Cas9 to target DNA in eukaryotic cells, enabling precise cleavage, mutagenesis, and SNP or indel detection without restriction sites.

Specific markers select high-quality chondrocytes and spheroids to produce transplantable cartilage with native-like matrix expression.

Omics-based HLA typing with De Bruijn graph analysis improves rare allele detection and speeds donor-recipient matching for transplants.

Blocking miR-448 relieves SCN5A suppression to raise Nav1.5 sodium current and reduce arrhythmic risk in cardiac cells.

MspA nanopore trapping resolves RNA and protein conformations from ionic current patterns without labeling, improving sensing consistency and resolution.

A curved substrate spreads dense labeled molecules for higher-throughput fluorescence sequencing with better signal attribution and contrast.

Computational scoring of H3K4me3 breadth and gene networks identifies cell identity factors for defined serum-free culture and cell conversion.

Single protein-to-particle attachment enables individual manipulation and detection while avoiding multi-particle binding that reduces accuracy.

Sequence-specific probes distinguish similar RNA species in mixtures, enabling identity, integrity, and quantity control for RNA production.

Programmable guide RNA and Cas9 enable targeted cleavage and RGEN-RFLP analysis at sites where standard restriction-based genotyping fails.

Electrical bridges formed by particles between electrodes replace optical readout, enabling single-molecule long-read DNA sequencing.

Tumor transcriptome analysis selects excessively upregulated RNA targets to build personalized cancer vaccines that break self-tolerance and improve tumor targeting.

A non-inhibitory colored dye makes transparent reverse transcriptase reagent transfers visible, helping confirm small volumes by eye.

Direct DNA-switch sensing converts biomarker binding into electrical signals for rapid, PCR-free detection with high sensitivity and reprogrammability.

CEMIP detection in primary tumor exosomes identifies brain metastasis risk and supports targeted inhibition of vascular invasion and colonization.

SNP markers on chromosome N13 enable precise, high-throughput selection of low-fiber canola lines, shortening breeding cycles.

Electrodeposited mediator layers replace screen printing to improve biosensor uniformity, sensitivity, and solvent-free analyte detection.

A composite membrane balances oxygen permeability and glucose regulation to improve implantable glucose sensor accuracy, stability, and life.

Stable isolated binding domains capture DNA or RNA without sequence bias, then release it under mild conditions for easier downstream use.

Circular mtDNA-aware alignment and filtering improve detection of deletions, insertions, duplications, and inversions in sequencing reads.

Reactive nucleoside analog labeling and sequencing map DNA repair sites in non-dividing cells where conventional lesion detection lacks precision.

Selected methylation marker panels improve lung cancer screening by separating malignant from benign nodules and distinguishing cancer types.

Multiple genotype sequences are combined into one cellular reference material, reducing control complexity and improving cancer assay coverage.

Genetic markers such as MYC alterations help predict which solid cancer patients may respond better to imidazopyridine CLK inhibitor therapy.

Targeted methylation PCR of CG2-15, LINC00682, and NBPF13P enables early lung cancer detection and prognosis from tissue or plasma.

Differential-complementarity probes enrich rare variant nucleic acids over wild type, cutting sequencing reads while improving detection specificity.

Multiplex digital PCR with labeled probes quantifies HDR, NHEJ, and wild-type sequences in one assay to optimize genome editing conditions.

Deoxygenated calibration fluids are pre-oxygenated in permeable tubing loops, cutting IVD sensor calibration delay without blocking pumps.

Cell-free DNA in perfusion or flush fluids helps predict organ suitability and guides perfusion parameter adjustment before transplantation.

SYT11 and related gene expression markers improve diffuse gastric cancer diagnosis, prognosis, and treatment selection beyond invasive screening.

A template-switch polymerization reaction adds directional adapters to RNA in one pot, improving sensitivity and amplification from low-input samples.

Cleavable labels and pre-amplifier cascades expand RNA ISH multiplexing while preserving sensitivity and reducing sequential detection time.

Using separate nucleotide flows and match scores, this case improves SNP and indel detection accuracy without costly high-depth sequencing.

High polymerase and primer concentrations enable PCR cycles under 20 seconds while preserving yield and accuracy during extreme thermal ramping.

Conserved-sequence primer-probe sets plus an internal control enable broad mycoplasma qPCR detection in 4 hours while preventing false negatives.

Immobilized transposome complexes fragment and tag DNA without PCR, improving GC-rich coverage, indel calling, and prep speed.

Universal probe binding regions and target barcodes enable multiplex nucleic acid detection with high specificity while reducing probe design complexity.

Maternal SPINT1 and SYNDECAN-1 assays improve detection of placental insufficiency when ultrasound misses fetal growth restriction.

Dual DNA barcodes link mutated coding regions to short-read sequencing, improving variant resolution while lowering sequencing cost.

BACH1 expression, alone or with FOXA1, helps evaluate pancreatic cancer EMT, metastasis, and prognosis while supporting metastasis suppressant screening.

Modified LNA primers and probes improve digital PCR specificity for distinguishing tumor-derived HPV and EBV DNA from infectious viral DNA.

Parallel-oriented primers and exonuclease-negative polymerase improve liquid biopsy detection of DNA rearrangements over wild-type DNA.

Known SNPs guide candidate paths in a genomic DAG, excluding incongruent alignments to improve NGS read mapping speed and accuracy.

Blood lipid, glycan, hormone, and fatty acid markers replace liver biopsy for sensitive NAFLD, NASH, and fibrosis diagnosis.

Internal and external controls stabilize qPCR after restriction digestion, enabling automated methylation analysis from FFPE and single-stranded DNA.

Stacked z-level flow cell imaging and image registration resolve overlapped clusters, boosting 3D sequencing throughput without extra primers.

A movable filling portion handles extraction and amplification reagents in separate zones, shrinking nucleic acid testers without cross-contamination.

Cannula-coating and drying create thicker electrode edges, preventing sensor drift while cutting ablation, time, and cost.

Direct ITC tracking of lipolysis in minimally diluted human plasma reveals LPL kinetics and regulator effects without labeled substrates.

Covalent ABPP probes enrich low-abundance host cell lipases that degrade polysorbate, enabling more specific mass spectrometry detection.

Adding longer gDNA fragments to cfDNA sequencing helps separate germline from somatic variants when allelic fractions are noisy.

Specific genomic fragments on chromosomes 4 and 9 give Beta vulgaris durable Cercospora resistance without reducing agronomic performance.

Magnetic nanoparticles with attached primers enable electrochemical coronavirus detection in under 10 minutes while reducing PCR cycles.

Molecular markers improve petunia-calibrachoa selection precision despite trait masking, enabling stable, uniform breeding lines.

Targeted probe panels capture bacterial DNA, 16S rRNA, virulence factors, and AMR genes to speed accurate diagnosis and antibiotic selection.

Codon-optimized OgLuc variants and new coelenterazine substrates improve luminescence stability, expression, and assay compatibility.

Template-independent stem-loop probes enable single ligation events and more accurate nucleotide detection with less hybridization bias.

Measuring cell-free nucleosomes helps predict DNA yield and set sample volume before sequencing, improving liquid biopsy reliability.

Patterned surface free energy confines the reagent layer to a defined electrode area, improving sensor detection accuracy and layer uniformity.

Encoded probes delivered in defined spatial patterns enable high-resolution, high-multiplex mapping of biological targets with digital sequencing readout.

A hydrophobic-tagged DNA sensor crosses lipid membranes to detect intracellular nucleic acids without lysis, preserving rare cell populations.

Pre-operative bodily fluid sequencing builds a tumor-informed genome reference for sensitive monitoring of residual disease, metastasis, and therapy response.

Magnetic separation and oligonucleotide barcodes enable sensitive multiplex protein quantitation in complex fluids with qPCR or NGS.

Gene signature panels quantify TEAD pathway activity to predict inhibitor response, guide trials, and monitor cancer treatment efficacy.

Uniform parental tomato lines are crossed to deliver stable F1 plants with stacked resistance traits, compact growth, and consistent yield.

Zirconium silicate bead lysis and silica magnetic bead capture shorten sample prep while preserving clean nucleic acid templates for detection.

Chemical inactivation on a solid saliva matrix preserves analytes for accurate testing while enabling safe ambient transport without cold chain.

Specific exosomal miRNAs predict PARP inhibitor response and prognosis while helping identify resistance early through FOXM1-linked sensitivity.

Controlled MDA synchronizes second-strand generation in paired-end sequencing, improving read alignment and mutation detection.

Non-spherical disrupting particles and chaotropic lysis improve plant cell breakage while removing polysaccharide and polyphenol inhibitors.

Internal fragment size controls track extraction and enrichment bias in cfDNA assays, improving tumor assessment and contamination detection.

PTK2B mRNA expression in blood, plasma, or serum enables earlier and more reliable obesity risk prediction than traditional assessment.

A 65-gene PROSIBLAD signature improves NMIBC progression risk stratification, guiding tailored treatment and reducing unnecessary surveillance.

Thousands of microdroplets enable parallel digital PCR with wider dynamic range, multiplex target detection, and less repeat testing.

Site-specific nucleases trigger recombination at selected loci to break unfavorable trait linkages and speed disease-resistant plant breeding.

A stable New Guinea Impatiens breeding line improves trait predictability while supporting novel color, growth habit, and hardiness development.

Selective nuclease digestion removes host genomic material so nanopore sequencing can identify viral contaminants within one workday.

Mechanical shape changes are converted into electrical signals, enabling accurate sequence detection with lower detector complexity and cost.

Captures both 5' and 3' nucleic acid ends on spatial barcoded arrays to map multiple analytes in tissue with fuller gene expression context.

Random primers, exonuclease-free polymerase, and ligation repair 3′ overhang DNA while preserving end sequence information.

Unique molecular identifiers and family-based consensus sequencing separate true rare mutations from instrument errors and cut false positives.

Ribosome-bound mRNA isolation enables rapid, sensitive AMR detection from clinical samples without culturing or DNA false positives.

Shared hybridization sites create uniform background signal in multiplex protein assays, separating true positives by paired barcodes without a separate control.

Virtual screening, saturation mutation, and base substitution improve aptamer specificity and affinity for sensitive mycotoxin detection.

Partial sequence reads from maternal cell-free DNA are normalized against reference genomes to detect fetal genetic variations without invasive sampling.

Solid-support peptide coupling and peptidase degradation reduce sample loss and polypeptide input in protein sequencing.

An optimized phase or amplitude mask extends sequencer depth of field, preserving focus accuracy, lowering noise, and improving throughput.

Patient-specific tumor sequencing and cfDNA biomarker panels improve early recurrence detection by tracking relapse-driving clones.

Stool microbiomics, flow cytometry, and RNA profiling enable earlier non-invasive NEC risk assessment in premature newborns.

Thermoplastic microspheres isolate enzymes from magnesium ions, enabling single-tube nucleic acid amplification with preserved activity and faster testing.

Reduced DOC2B levels in blood or islet samples enable earlier detection of β-cell dysfunction and diabetes risk than static autoantibody screening.

Drug-degrading enzyme extracts are mixed with antibiotics and read by mass spectrometry to identify resistant microorganisms without culturing.

A bilayer membrane and multiple enzymes enable one analyte sensor to detect several analytes while balancing permeability, stability, and size.

Targeted stacked mutations and CSR selection improve Taq PCR amplification in the presence of humic acid, heparin, and hematin.

A concentric disk ETP layout shifts electromigration into two dimensions to compress large biological samples into smaller, sharper bands.

Multiple barcode beads per partition are resolved by comparing read overlaps, improving partition use without losing sequencing sensitivity.

A free primer binds the template 3′ end more strongly than surface oligos, enabling low-noise second index sequencing before paired-end turn.

Biotin-labeled RCA products are compacted with avidin or streptavidin to stabilize in situ signals and improve detection resolution.

Control slides with fiducial markers and fluorescent probes pre-calibrate spatial imaging, improving alignment, resolution, and heating consistency.

Segmented centrifugation isolates platelets from plasma for individual lysis, preventing activation-induced exocytosis that distorts immunoassay results.

Normalized urine mRNA expression of DLX1 and HOXC6 predicts clinically significant prostate cancer, reducing unnecessary biopsies in low PSA patients.

Identify incurable early-stage cancer by detecting aberrant PDPK FA and GSK-3α accumulation in bone marrow-derived stem cells.

A phenotype dosage sensitivity model quantifies gene expression intensity to predict clinical outcomes from LGD mutations.

Detecting prohibitin binding to the pitx1 promoter identifies osteoarthritis risk through molecular interaction analysis.

Astroglial cells cultivated under thiamine deficiency quantify yokukansan pharmacological activity via glutamic acid and neutral red intake levels.

Engineered enAsCas12a enzyme enables rapid viral nucleic acid detection using a single heat block and hybrid guides.

Dam enzymatic marking records interactions in isolated cells, preserving biological heterogeneity lost in bulk population averages.

Oligonucleotide-conjugated beads capture single-cell mRNA to resolve heavy and light chain pairings in high-throughput immune repertoire analysis.

A real-time microarray system measures analyte binding using surface plasmon resonance and quenching moieties.

Computational identification of surface-exposed S. aureus antigens replaces empirical protein purification, reducing vaccine development time and labor costs.

Dual mediator biosensor uses cytochrome C and ferricyanide to enhance electron transfer rates, enabling rapid arsenite detection in water samples.

Analyzing microvesicular RNA biomarkers from blood samples identifies kidney transplant rejection without invasive biopsies.

A non-invasive method for detecting fetal chromosomal copy number variations using targeted DNA sequencing and library preparation.

Specific amino acid substitutions in the 3′ block binding pocket improve incorporation of modified nucleotides while reducing pyrophosphorolysis errors.

Molecular markers detect drought tolerance alleles, resolving unclear genetic contributions and accelerating breeding efficiency.

Carrier gas saturated with water vapor prevents preferential water evaporation, maintaining stable hydrogen peroxide concentration for safe decontamination.

Serum biomarkers replace invasive biopsies to monitor fibrosis progression, reducing patient stress and sampling errors.

CD248 methylation analysis detects naïve CD8+ T-cells directly in whole blood, bypassing cumbersome purification and staining procedures.

Metagenomics filtering detects allergens and toxigens via sequence data, resolving the contradiction between high throughput and detection specificity.

Ultra-low coverage sequencing identifies rare variants and cryptic relationships by applying statistical inference to sparse aligned reads.

Nucleosomal DNA proficiency standards simulate natural cell-free samples, resolving scarcity issues in prenatal and cancer diagnostic testing.

XNA aptamer particle display libraries employ artificial genetic polymers to overcome enzymatic digestion and improve in vivo stability.

Anti-CwpV antibodies identify ribotype 027 strains through ELISA, replacing complex PCR workflows to reduce testing duration.

Oligonucleotide probes detect specific gene expression patterns in blood samples to identify proliferative disorders.

Genotyping specific SNP markers on bovine chromosome 21 identifies brachyspina carriers through DNA analysis.

Specific oligonucleotides target the 450 region of Listeria 16S rRNA for nucleic acid amplification.

Segmented strip port connectors read encoded information through independent contact pairs, detecting damaged pins to ensure reliable meter readings.

AEGIS nucleotides and segmented reverse displaceable probes resolve interference from natural nucleic acids during isothermal amplification.

Aligns partial sequence data during generation to identify structural variants, reducing analysis time from 45 hours by enabling early variant reporting.

Measuring cellular redox potential determines cell cycle phases without fluorescent dyes.

A MYH3 gene marker detects pig meat quality traits through DNA analysis.

A urine analyzer switches between sample modes using a specimen preparing section to mix reagents for accurate particle detection.

Applying electric fields moves labeled moieties closer to tunneling junctions, enabling fast nucleotide detection without sub-nanometer gap fabrication.

A biological sample analysis device integrates a rough bearing surface to mechanically lyse species within a single chamber.

Mechanical cell disruption through a microfluidic constriction delivers Cas9 complexes, avoiding viral vectors and minimizing off-target effects.

Reverse transcription converts RNA to cDNA for padlock probe hybridization, resolving low specificity in FFPE samples.

Antifoam agents suppress foaming in cell-free protein synthesis, enabling high oxygen transfer and increased yields in large-scale aerobic reactions.

Automated badge-based inference identifies causal structural variants, reducing manual curation time while maintaining diagnostic accuracy.

TaqMan PCR assay analyzes cell-free nucleic acids from embryo culture media for preimplantation genetic diagnosis.

Electronic detection replaces fluorescent labeling to cut sequencing costs while maintaining clinical-grade accuracy.

Analyzing YAP activity in cancer cells guides caspase-3 inhibitor selection, improving therapeutic effectiveness by targeting non-apoptotic roles.

Differential CpG methylation patterns enable isolation of fetal nucleic acid from maternal plasma, eliminating invasive sampling risks for prenatal diagnosis.

A method for generating full-length RNAs through in situ surface transcription and immediate aptamer-mediated immobilization.

Diagnostic kit detects D-lactic acid and hydrogen peroxide levels via enzyme-based colorimetric assays for rapid vaginal health assessment.

A holographic three-dimensional multi-spot light stimulation device generates spatial light patterns to target multiple cells simultaneously.

Reversible layer seals create a gasket-free flow path with an optical window, resolving the trade-off between seal reliability and device complexity.

Genotyping the FcγR2a His131 allele selects patients for anti-FcRn therapy, avoiding adverse side effects from ineffective treatments.